Zagon and McLaughlin32,33 documented the presence of the opioid growth factor receptor(OGFr) axis in a number of human cancers including neuroblastoma, pancreatic, colon,breast, renal, squamous cell carcinoma of the head and neck, and hepatocellularadenoma. This evidence concerns the gene OGFR and neuroblastoma.